Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
14.00
|
15.00
|
14.50
|
14.04
|
14.78
|
14.06
|
|
|
1 800 000.00
|
|
14.60
|
14.90
|
15.50
|
14.60
|
15.50
|
14.74
|
|
|
2 290 000.00
|
|
15.06
|
15.22
|
15.34
|
14.74
|
15.56
|
15.22
|
|
|
749 540.00
|
|
15.14
|
15.22
|
16.40
|
14.98
|
16.40
|
15.16
|
|
|
2 430 000.00
|
|
15.10
|
15.42
|
14.68
|
14.64
|
15.60
|
15.10
|
|
|
4 330 000.00
|
|
14.54
|
14.94
|
14.64
|
14.32
|
14.96
|
14.94
|
|
|
1 990 000.00
|
|
14.40
|
14.72
|
14.70
|
14.26
|
15.28
|
14.64
|
|
|
1 920 000.00
|
|
14.32
|
14.54
|
14.60
|
14.20
|
14.82
|
14.32
|
|
|
962 560.00
|
|
14.32
|
14.58
|
14.54
|
14.14
|
14.74
|
14.58
|
|
|
478 180.00
|
|
14.12
|
14.28
|
13.58
|
13.58
|
14.36
|
14.28
|
|
|
1 780 000.00
|
|
ImmuneOnco Biopharmaceuticals Shanghai Co Ltd is a China-based company mainly testing biotechnology research and development. The Company's main businesses include the development of biotechnology for the systemic utilization of innate and adaptive immunity, and the development of next-generation tumor immunotherapies, which primarily focus on the adaptive immune system. The Company operates in the domestic market and overseas markets.